$31.71
-0.64-1.98%
Last update: Oct 23, 9:04 AM
Caris Life Sciences Inc (CAI) Stock Price, Quote, News & History
CAINASDAQ
The Nasdaq 100 fell 1% by midday Wednesday after September CPI topped forecasts, pushing Treasury yields and rate-hike bets higher.
You can purchase shares of Caris Life Sciences (NASDAQ:CAI) through any online brokerage.
Other companies in Caris Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Caris Life Sciences has a consensus price target of $30.15.
The stock price for Caris Life Sciences (NASDAQ: CAI) is $31.38 last updated October 23, 2026 at 9:04 AM EDT.
There are no upcoming dividends for Caris Life Sciences.
Caris Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Caris Life Sciences.
Caris Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning...
